InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

MOLECULAR PARTNERS AG

MOLN Clue Score26
Switzerland Fiscal year ends December CIK 0001745114
$3.79 -1.56% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.79 −80.64% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 16 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue20.4Operating income−36.7Net income−36.3EPS, diluted−1.69Fiscal year 2020Revenue9.3 −54.2%Operating income−58.3Net income−62.8EPS, diluted−2.51Fiscal year 2021Revenue9.8 +4.4%Operating income−63.4Net income−63.8EPS, diluted−2.06Fiscal year 2022Revenue189.6 +1,843.8%Operating income116.6Net income117.9EPS, diluted3.54Fiscal year 2023Revenue7.0 −96.3%Operating income−61.1Net income−62.0 −152.6%EPS, diluted−1.89 −153.4%Fiscal year 2024Revenue5.0 −29.4%Operating income−61.2Net income−54.0EPS, diluted−1.59Fiscal year 2025Revenue0.0 −100.0%Operating income−58.1Net income−61.7EPS, diluted−1.65
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 20.4 9.3 9.8 189.6 7.0 5.0 0.0
Growth −54.2% +4.4% +1,843.8% −96.3% −29.4% −100.0%
Operating income −36.7 −58.3 −63.4 116.6 −61.1 −61.2 −58.1
Net income −36.3 −62.8 −63.8 117.9 −62.0 −54.0 −61.7
Growth −152.6%
EPS, diluted −1.69 −2.51 −2.06 3.54 −1.89 −1.59 −1.65
Growth −153.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−179.9%Net margin−178.0%Free cash flow margin−10.9%Fiscal year 2020Operating margin−624.2%Net margin−671.7%Free cash flow margin−325.7%Fiscal year 2021Operating margin−650.2%Net margin−653.9%Free cash flow margin−942.0%Fiscal year 2022Operating margin61.5%Net margin62.2%Free cash flow margin61.9%Fiscal year 2023Operating margin−868.3%Net margin−880.7%Free cash flow margin−846.5%Fiscal year 2024Operating margin−1,231.7%Net margin−1,087.4%Free cash flow margin−1,206.3%Fiscal year 2025
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −179.9% −624.2% −650.2% 61.5% −868.3% −1,231.7% n/a
Net margin −178.0% −671.7% −653.9% 62.2% −880.7% −1,087.4% n/a
Free cash flow margin −10.9% −325.7% −942.0% 61.9% −846.5% −1,206.3% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−1.2Capital expenditure−1.0Free cash flow−2.2Fiscal year 2020Operating cash flow−29.0Capital expenditure−1.5Free cash flow−30.4Buybacks0.0Fiscal year 2021Operating cash flow−91.0Capital expenditure−0.9Free cash flow−91.9Buybacks0.0Fiscal year 2022Operating cash flow118.6Capital expenditure−1.2Free cash flow117.4Buybacks−0.6Fiscal year 2023Operating cash flow−59.0Capital expenditure−0.6Free cash flow−59.6 −150.8%Buybacks0.0Fiscal year 2024Operating cash flow−59.2Capital expenditure−0.7Free cash flow−60.0Buybacks0.0Fiscal year 2025Operating cash flow−51.3Capital expenditure−0.7Free cash flow−52.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.2 −29.0 −91.0 118.6 −59.0 −59.2 −51.3
Capital expenditure −1.0 −1.5 −0.9 −1.2 −0.6 −0.7 −0.7
Free cash flow −2.2 −30.4 −91.9 117.4 −59.6 −60.0 −52.0
Growth −150.8%
Buybacks n/a 0.0 0.0 −0.6 0.0 0.0 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash75.7Shareholders’ equity54.1Fiscal year 2020Cash133.7Shareholders’ equity107.2Fiscal year 2021Cash71.8Shareholders’ equity107.3Fiscal year 2022Cash87.9Shareholders’ equity235.2Fiscal year 2023Cash67.3Shareholders’ equity176.4Fiscal year 2024Cash63.9Shareholders’ equity141.6Fiscal year 2025Cash82.7Shareholders’ equity80.3
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 75.7 133.7 71.8 87.9 67.3 63.9 82.7
Shareholders’ equity 54.1 107.2 107.3 235.2 176.4 141.6 80.3

In millions of CHF, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of CHF, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
20.4 9.3 9.8 189.6 7.0 5.0 0.0
Growth −54.2% +4.4% +1,843.8% −96.3% −29.4% −100.0%
43.5 56.1 55.7 50.7 48.8 48.6 40.2
13.5 11.6 17.5 22.2 19.4 17.6 15.2
−36.7 −58.3 −63.4 116.6 −61.1 −61.2 −58.1
Growth −152.4%
−36.3 −62.8 −63.8 117.9 −62.0 −54.0 −61.6
0.0 −0.0 0.0 0.0 0.0 0.0 0.0
−36.3 −62.8 −63.8 117.9 −62.0 −54.0 −61.7
Growth −152.6%
Per share
−1.69 −2.51 −2.06 3.63 −1.89 −1.59 −1.65
−1.69 −2.51 −2.06 3.54 −1.89 −1.59 −1.65
Growth −153.4%
21.4 25.0 31.0 32.5 32.8 34.0 37.3
21.4 25.0 31.0 33.3 32.8 34.0 37.3
Growth +16.8% +24.0% +7.3% −1.5% +3.9% +9.5%

Shown in CHF as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • The diluted share count rose 49.1% in five years, which is dilution.
  • A net loss in 6 of 7 years on file.